A paradigm shift in studies based on rheumatoid arthritis clinical registries
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Clinical research is the study of aspects of patient health or illness that are closely related to clinical practice. In the late 20th and early 21th century, outcomes for patients with rheumatoid arthritis (RA) improved dramatically due to breakthroughs in new drugs. Patient-reported outcome measures now play a significant role in the drug development process as study endpoints in clinical trials of new therapies, and this has led to increased interest in the patient's perspective, drug safety and treatment outcomes in clinical practice. In accordance with these needs, many prospective cohorts for RA patients and registries of biologic disease modifying anti-rheumatic drugs have been actively conducted in the United States and European and Asian countries. A gradual shift is taking place in the major outcomes of clinical research using these prospective cohorts and registries. This article will introduce representative registries for RA in each country set up in the early 2000s and will discuss future perspectives in clinical research on RA patients using such clinical registries.
Abstract
Clinical research is the study of aspects of patient health or illness that are closely related to clinical practice. In the late 20th and early 21th century, outcomes for patients with rheumatoid arthritis (RA) improved dramatically due to breakthroughs in new drugs. Patient-reported outcome measures now play a significant role in the drug development process as study endpoints in clinical trials of new therapies, and this has led to increased interest in the patient's perspective, drug safety and treatment outcomes in clinical practice. In accordance with these needs, many prospective cohorts for RA patients and registries of biologic disease modifying anti-rheumatic drugs have been actively conducted in the United States and European and Asian countries. A gradual shift is taking place in the major outcomes of clinical research using these prospective cohorts and registries. This article will introduce representative registries for RA in each country set up in the early 2000s and will discuss future perspectives in clinical research on RA patients using such clinical registries.
참고문헌 (64)
- Furner SE, "Health-related quality of life of US adults with arthritis : analysis of data from the behavioral risk factor surveillance system, 2003, 2005, and 2007", Arthritis Care Res(Hoboken), 63, pp.788~799 (2011)
- Gladman DD, "Longitudinal cohort studies", J Rheumatol Suppl, 72, pp.30~32 (2005)
- Garrison L, "Etanercept: therapeutic use in patients with rheumatoid arthritis", Ann Rheum Dis, (58 Suppl 1), pp.65~69 (1999)
- Willke RJ, "Measuring treatment impact : a review of patient-reported outcomes and other efficacy endpoints in approved product labels", Control Clin Trials, 25, pp.535~552 (2004)
- Smolen JS, "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs : 2013 update", Ann Rheum Dis, 73, pp.492~509 (2014)
- Kremer JM, "The Corrona US registry of rheumatic and autoimmune diseases", Clin Exp Rheumatol, 34(5 Suppl 101), pp.S96~S99 (2016)
- 조수경, "류마티스 질환의 코호트 연구", 대한내과학회지, 87(5), pp.548~556 (2014), 대한내과학회[DOI]
- Kremer J., "The CORRONA database", Ann Rheum Dis, (64 Suppl 4), pp.iv37~iv41 (2005)
- Iannaccone CK, "Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy : data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study", Rheumatology(Oxford), 50, pp.40~46 (2011)
- Yamanaka H, "Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice", Mod Rheumatol, 16, pp.75~76 (2006)
- Alemao E, "Association of anti-cyclic citrullinated protein antibodies, erosions, and rheumatoid factor with disease activity and work productivity : a patient registry study", Semin Arthritis Rheum, 47, pp.630~638 (2018)
- Hetland ML, "Monitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registry", Clin Exp Rheumatol, 32(5 Suppl 85), pp.S-141~S-146 (2014)
- Rutherford AI, "Serious infection across biologic-treated patients with rheumatoid arthritis : results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis", Ann Rheum Dis, 77, pp.905~910 (2018)
- Yano K, "Features of patients with rheumatoid arthritis whose debut joint is a foot or ankle joint : a 5, 479-case study from the IORRA cohort", PLoS One, 13, pp.e0202427~ (2018)
- Sakai R, "The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time : a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety(REAL)database", Rheumatol Int, 34, pp.1729~1736 (2014)
- Han M, "Factors associated with the use of complementary and alternative medicine for Korean patients with rheumatoid arthritis", J Rheumatol, 42, pp.2075~2081 (2015)
- Jung SM, "Risk factors associated with inadequate control of disease activity in elderly patients with rheumatoid arthritis : results from a nationwide Korean College of Rheumatology BIOlogics(KOBIO)registry", PLoS One, 13, pp.e0205651~ (2018)
- Tutuncu Z, "Do patients with older-onset rheumatoid arthritis receive less aggressive treatment?", Ann Rheum Dis, 65, pp.1226~1229 (2006)
- Ranganath VK, "Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug(DMARD)associated with frequent changes in DMARD : the CORRONA database", J Rheumatol, 35, pp.1966~1971 (2008)
- Greenberg JD, "Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry", Ann Rheum Dis, 69, pp.380~386 (2010)
- Navarro-Millan I, "Predictors and persistence of new-onset clinical remission in rheumatoid arthritis patients", Semin Arthritis Rheum, 43, pp.137~143 (2013)
- Ranganath VK, "Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis", Rheumatology(Oxford), 52, pp.1809~1817 (2013)
- Mease PJ, "Clinical characteristics, disease activity, and patient-reported outcomes in psoriatic arthritis patients with dactylitis or enthesitis : results from the Corrona Psoriatic Arthritis", Spondyloarthritis Registry, 2017, pp.69, 1692~1699
- Sato M, "The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28", Arthritis Res Ther, 8, pp.R57~ (2006)
- Karlson EW, "Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study", Ann Rheum Dis, 67, pp.358~363 (2008)
- Lee YC, "Pain persists in DAS28 rheumatoid arthritis remission but not in ACR", EULAR remission : a longitudinal observational study, 2011, pp.13, R83~
- Prince FH, "Sustained rheumatoid arthritis remission is uncommon in clinical practice", Arthritis Res Ther, 14, pp.R68~ (2012)
- Lillegraven S, "Remission and radiographic outcome in rheumatoid arthritis : application of the 2011 ACR", EULAR remission criteria in an observational cohort, 2012, pp.71, 681~686
- Lillegraven S, "Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis", Arthritis Care Res(Hoboken), 65, pp.526~533 (2013)
- Doyle TJ, "Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis", Chest, 146, pp.41~50 (2014)
- Brown LE, "Clinical characteristics of RA patients with secondary SS and association with joint damage", Rheumatology(Oxford), 54, pp.816~820 (2015)
- Radner H, "Development of a multimorbidity index : impact on quality of life using a rheumatoid arthritis cohort", Semin Arthritis Rheum, 45, pp.167~173 (2015)
- Liao KP, "The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis", J Am Heart Assoc, 4, pp.e001588~ (2015)
- Ahmad HA, "Association of low bone mineral density with anti-citrullinated protein antibody positivity and disease activity in established rheumatoid arthritis : findings from a US observational cohort", Adv Ther, 35, pp.232~242 (2018)
- Hellgren K, "Cancer risk in patients with spondyloarthritis treated with TNF inhibitors : a collaborative study from the ARTIS and DANBIO registers", Ann Rheum Dis, 76, pp.105~111 (2017)
- Askling J, "Swedish registers to examine drug safety and clinical issues in RA", Ann Rheum Dis, 65, pp.707~712 (2006)
- Hetland ML, "Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO)", Scand J Rheumatol, 34, pp.40~44 (2005)
- Lie E, "First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011 : data from the NOR-DMARD register", Ann Rheum Dis, 73, pp.1905~1906 (2014)
- Silman A, "British society for rheumatology biologics register", Ann Rheum Dis, (62 Suppl 2), pp.ii28~ii29 (2003)
- Dixon WG, "Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy : results from the British Society for Rheumatology Biologics Register", Arthritis Rheum, 54, pp.2368~2376 (2006)
- Forsblad-d'Elia H, "Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis : results from the Swedish biologics register", Rheumatology(Oxford), 54, pp.1186~1193 (2015)
- Askling J, "Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas : relative risks and time trends in the Swedish Biologics Register", Ann Rheum Dis, 68, pp.648~653 (2009)
- Raaschou P, "Tumor necrosis factor inhibitors and cancer recurrence in Swedish patients with rheumatoid arthritis : a nationwide population-based cohort study", Ann Intern Med, 169, pp.291~299 (2018)
- Wadstrom H, "Malignant neoplasms in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors, tocilizumab, abatacept, or rituximab in clinical practice : a nationwide cohort study from Sweden", JAMA Intern Med, 177, pp.1605~1612 (2017)
- Mercer LK, "Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis", Ann Rheum Dis, 76, pp.497~503 (2017)
- Michaud K, "Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease", Ann Rheum Dis, 75, pp.1797~1805 (2016)
- Curtis JR, "A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries", Semin Arthritis Rheum, 40, pp.2~14 (2010)
- Askling J, "How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries", Ann Rheum Dis, 75, pp.1789~1796 (2016)
- Mercer LK, "Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis : a European registries collaborative project", Ann Rheum Dis, 76, pp.2025~2030 (2017)
- Nakajima A, "Disability and patient's appraisal of general health contribute to depressed mood in rheumatoid arthritis in a large clinical study in Japan", Mod Rheumatol, 16, pp.151~157 (2006)
- Tanaka E, "Efficient management of rheumatoid arthritis significantly reduces long-term functional disability", Ann Rheum Dis, 67, pp.1153~1158 (2008)
- Shidara K, "Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA", Mod Rheumatol, 20, pp.280~286 (2010)
- Yamada T, "Incidence of malignancy in Japanese patients with rheumatoid arthritis", Rheumatol Int, 31, pp.1487~1492 (2011)
- Komano Y, "Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors : a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety", J Rheumatol, 38, pp.1258~1264 (2011)
- Sakai R, "Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients(RA)in clinical practice : results from the registry of Japanese RA patients on biologics for long-term safety(REAL)registry", Arthritis Res Ther, 17, pp.74~ (2015)
- Sung YK, "Korean Observational Study Network for Arthritis(KORONA) : establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea", Semin Arthritis Rheum, 41, pp.745~751 (2012)
- Cho SK, "Do patients with elderly-onset rheumatoid arthritis have severe functional disability?", Semin Arthritis Rheum, 42, pp.23~31 (2012)
- 김담, "Impact of early diagnosis on functional disability in rheumatoid arthritis", The Korean Journal of Internal Medicine, 32(4), pp.738~746 (2017), 대한내과학회[DOI]
- Kim D, "Incidence and risk factors of fractures in patients with rheumatoid arthritis : an Asian prospective cohort study", Rheumatol Int, 36, pp.1205~1214 (2016)
- Kim D, "Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis", Rheumatol Int, 37, pp.1735~1745 (2017)
- Sung YK, "Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis", Rheumatol Int, 37, pp.975~982 (2017)
- Park DJ, "Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy : results from the KOBIO registry", Clin Rheumatol, 36, pp.1013~1022 (2017)
- Dixon WG, "Using technology to support clinical care and research in rheumatoid arthritis", Curr Opin Rheumatol, 30, pp.276~281 (2018)
- Curtis JR, "Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research", Arthritis Care Res(Hoboken), 66, pp.1790~1798 (2014)
